Sep. 12, 2024 — Researchers have created 'smart' microparticles that self-assemble in response to the addition of a specific molecule. This work can help explain the behavior of biomolecular ...

Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning! Today, we discuss the woman who spearheaded progress in ...

However, many question whether this is a healthy or sustainable approach for either party, leading to many questions: What has been the true impact of M&amp,A on the biotech space? How has the ...

Check if you have access via personal or institutional login Practical Techniques in Molecular Biotechnology intends to familiarise students with the basics of the well-known experiments of molecular ...

After raising $213 million in 2023—one of the year’s largest private biotech rounds—Tome Biosciences is making cuts. “Despite our clear scientific progress, investor sentiment has shifted ...

Looking for the best biotech penny stocks? The most important innovation of the 1990s was the internet — today, it would be a vaccine for COVID-19. If these times have anything to say about it ...

These companies are nearly in the sweet spot of risk versus reward in biotech. Many investors rightfully identify biotech stocks as being riskier than average, and those stocks certainly have a ...

An investment in these players today could score a big win down the road. Why do investors love biotech stocks? Because these players often work on game-changing technology that could lead to ...

Another source reported that there are still options on the table to keep the biotech running. Both spoke on condition of anonymity to be able to speak candidly. In a statement, a spokesperson for ...

MBX Biosciences has added to the recent flurry of IPO filings. The biotech, which filed its paperwork weeks after raising $63.5 million privately, is seeking funding to take a would-be challenger ...

HYDERABAD, Aug 27 (Reuters) - India's Bharat Biotech said on Tuesday its oral cholera vaccine cleared a late-stage trial and that it plans a global launch, aiming to make up to 200 million doses a ...